+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Gastroesophageal Reflux Disease Devices Market Research Report by Product Type, Procedure Type, Device Type, Surgery Type, Route of Administration, Dosage Form, End-User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 157 Pages
  • October 2022
  • Region: United States
  • 360iResearch™
  • ID: 5456958
UP TO OFF until Dec 31st 2022
The United States Gastroesophageal Reflux Disease Devices Market size was estimated at USD 925.96 million in 2021, USD 1,103.83 million in 2022, and is projected to grow at a CAGR of 15.47% to reach USD 2,195.88 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Gastroesophageal Reflux Disease Devices to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product Type, the market was studied across Diagnostic Devices, Esophagoscopes and Gastroscopes, Fundoplication Devices, Manometry System, PH Monitoring System, Radiofrequency Ablation Devices, Sphincter Augmentation Devices, Treatment Devices, and Ultrasonic Surgical Endostapler.
  • Based on Procedure Type, the market was studied across Diagnostic Procedures, Fundoplication Procedures, Magnetic Sphincter Augmentation, and Radiofrequency Thermal Ablation.
  • Based on Device Type, the market was studied across Bravo Reflux Testing System, Digitrapper reflux testing system, LINX Management System, MUSE -Medigus Ultrasonic Surgical Endostapler, Others, and Stretta Therapy.
  • Based on Surgery Type, the market was studied across Invasive and Non-invasive. The Invasive is further studied across Linx Reflux Management and Medigus Ultrasonic Surgical Endostapler. The Non-invasive is further studied across Endocinch Endolumminal gastroplication, Endoscopic Plicator System, EsophyX, Plexiglas poly-methyl-methacrylate (PMMA) microspheres, and Stretta.
  • Based on Route of Administration, the market was studied across Oral and Parenteral.
  • Based on Dosage Form, the market was studied across Liquid and Solid.
  • Based on End-User, the market was studied across Government, Hospitals, Medical Practitioners, and Others.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. This ongoing research amplifies This research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Gastroesophageal Reflux Disease Devices market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Gastroesophageal Reflux Disease Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Gastroesophageal Reflux Disease Devices Market, including Addex Pharmaceuticals Ltd., Aros Pharma ApS, AstraZeneca Plc, C. R. Bard, Inc.,, Eisai Co., Ltd, EndoGastric Solutions, Inc., KARL STORZ SE & Co. KG, MediGus Ltd., Olympus Corporation, PENTAX Medical (Global), Pfizer Inc., Takeda Pharmaceutical Company Limited, and The Procter & Gamble Company.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Gastroesophageal Reflux Disease Devices Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Gastroesophageal Reflux Disease Devices Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Gastroesophageal Reflux Disease Devices Market?
4. What is the competitive strategic window for opportunities in the United States Gastroesophageal Reflux Disease Devices Market?
5. What are the technology trends and regulatory frameworks in the United States Gastroesophageal Reflux Disease Devices Market?
6. What is the market share of the leading vendors in the United States Gastroesophageal Reflux Disease Devices Market?
7. What modes and strategic moves are considered suitable for entering the United States Gastroesophageal Reflux Disease Devices Market?
Frequently Asked Questions about the U.S. Gastroesophageal Reflux Disease Devices Market

What is the estimated value of the U.S. Gastroesophageal Reflux Disease Devices Market?

The U.S. Gastroesophageal Reflux Disease Devices Market was estimated to be valued at $925.96 Million in 2021.

What is the growth rate of the U.S. Gastroesophageal Reflux Disease Devices Market?

The growth rate of the U.S. Gastroesophageal Reflux Disease Devices Market is 15.4%, with an estimated value of $2195.88 Million by 2027.

What is the forecasted size of the U.S. Gastroesophageal Reflux Disease Devices Market?

The U.S. Gastroesophageal Reflux Disease Devices Market is estimated to be worth $2195.88 Million by 2027.

Who are the key companies in the U.S. Gastroesophageal Reflux Disease Devices Market?

Key companies in the U.S. Gastroesophageal Reflux Disease Devices Market include Addex Pharmaceuticals Ltd., Aros Pharma ApS, AstraZeneca Plc, C. R. Bard, Inc.,, Eisai Co., Ltd, EndoGastric Solutions, Inc., KARL STORZ SE & Co. KG, MediGus Ltd. and PENTAX Medical (Global).

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Gastroesophageal Reflux Disease Devices Market, by Product Type
6.1. Introduction
6.2. Diagnostic Devices
6.3. Esophagoscopes and Gastroscopes
6.4. Fundoplication Devices
6.5. Manometry System
6.6. PH Monitoring System
6.7. Radiofrequency Ablation Devices
6.8. Sphincter Augmentation Devices
6.9. Treatment Devices
6.10. Ultrasonic Surgical Endostapler
7. Gastroesophageal Reflux Disease Devices Market, by Procedure Type
7.1. Introduction
7.2. Diagnostic Procedures
7.3. Fundoplication Procedures
7.4. Magnetic Sphincter Augmentation
7.5. Radiofrequency Thermal Ablation
8. Gastroesophageal Reflux Disease Devices Market, by Device Type
8.1. Introduction
8.2. Bravo Reflux Testing System
8.3. Digitrapper reflux testing system
8.4. LINX Management System
8.5. MUSE -Medigus Ultrasonic Surgical Endostapler
8.6. Others
8.7. Stretta Therapy
9. Gastroesophageal Reflux Disease Devices Market, by Surgery Type
9.1. Introduction
9.2. Invasive
9.3.1. Linx Reflux Management
9.3.2. Medigus Ultrasonic Surgical Endostapler
9.3. Non-invasive
9.4.1. Endocinch Endolumminal gastroplication
9.4.2. Endoscopic Plicator System
9.4.3. EsophyX
9.4.4. Plexiglas poly-methyl-methacrylate (PMMA) microspheres
9.4.5. Stretta
10. Gastroesophageal Reflux Disease Devices Market, by Route of Administration
10.1. Introduction
10.2. Oral
10.3. Parenteral
11. Gastroesophageal Reflux Disease Devices Market, by Dosage Form
11.1. Introduction
11.2. Liquid
11.3. Solid
12. Gastroesophageal Reflux Disease Devices Market, by End-User
12.1. Introduction
12.2. Government
12.3. Hospitals
12.4. Medical Practitioners
12.5. Others
13. California Gastroesophageal Reflux Disease Devices Market
13.1. Introduction
14. Florida Gastroesophageal Reflux Disease Devices Market
14.1. Introduction
15. Illinois Gastroesophageal Reflux Disease Devices Market
15.1. Introduction
16. New York Gastroesophageal Reflux Disease Devices Market
16.1. Introduction
17. Ohio Gastroesophageal Reflux Disease Devices Market
17.1. Introduction
18. Pennsylvania Gastroesophageal Reflux Disease Devices Market
18.1. Introduction
19. Texas Gastroesophageal Reflux Disease Devices Market
19.1. Introduction
20. Competitive Landscape
20.1. FPNV Positioning Matrix
20.1.1. Quadrants
20.1.2. Business Strategy
20.1.3. Product Satisfaction
20.2. Market Ranking Analysis, By Key Player
20.3. Market Share Analysis, By Key Player
20.4. Competitive Scenario
20.4.1. Merger & Acquisition
20.4.2. Agreement, Collaboration, & Partnership
20.4.3. New Product Launch & Enhancement
20.4.4. Investment & Funding
20.4.5. Award, Recognition, & Expansion
21. Company Usability Profiles
21.1. Addex Pharmaceuticals Ltd.
21.1.1. Business Overview
21.1.2. Key Executives
21.1.3. Product & Services
21.2. Aros Pharma ApS
21.2.1. Business Overview
21.2.2. Key Executives
21.2.3. Product & Services
21.3. AstraZeneca Plc
21.3.1. Business Overview
21.3.2. Key Executives
21.3.3. Product & Services
21.4. C. R. Bard, Inc.,
21.4.1. Business Overview
21.4.2. Key Executives
21.4.3. Product & Services
21.5. Eisai Co., Ltd
21.5.1. Business Overview
21.5.2. Key Executives
21.5.3. Product & Services
21.6. EndoGastric Solutions, Inc.
21.6.1. Business Overview
21.6.2. Key Executives
21.6.3. Product & Services
21.7. KARL STORZ SE & Co. KG
21.7.1. Business Overview
21.7.2. Key Executives
21.7.3. Product & Services
21.8. MediGus Ltd.
21.8.1. Business Overview
21.8.2. Key Executives
21.8.3. Product & Services
21.9. Olympus Corporation
21.9.1. Business Overview
21.9.2. Key Executives
21.9.3. Product & Services
21.10. PENTAX Medical (Global)
21.10.1. Business Overview
21.10.2. Key Executives
21.10.3. Product & Services
21.11. Pfizer Inc.
21.11.1. Business Overview
21.11.2. Key Executives
21.11.3. Product & Services
21.12. Takeda Pharmaceutical Company Limited
21.12.1. Business Overview
21.12.2. Key Executives
21.12.3. Product & Services
21.13. The Procter & Gamble Company
21.13.1. Business Overview
21.13.2. Key Executives
21.13.3. Product & Services
22. Appendix
22.1. Discussion Guide
22.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2021 VS 2027
FIGURE 3. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 7. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET DYNAMICS
FIGURE 8. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT TYPE, 2027
FIGURE 11. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2027 (USD MILLION)
FIGURE 12. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHAGOSCOPES AND GASTROSCOPES, 2018-2027 (USD MILLION)
FIGURE 13. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FUNDOPLICATION DEVICES, 2018-2027 (USD MILLION)
FIGURE 14. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MANOMETRY SYSTEM, 2018-2027 (USD MILLION)
FIGURE 15. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PH MONITORING SYSTEM, 2018-2027 (USD MILLION)
FIGURE 16. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2027 (USD MILLION)
FIGURE 17. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPHINCTER AUGMENTATION DEVICES, 2018-2027 (USD MILLION)
FIGURE 18. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2027 (USD MILLION)
FIGURE 19. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ULTRASONIC SURGICAL ENDOSTAPLER, 2018-2027 (USD MILLION)
FIGURE 20. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2021 VS 2027 (%)
FIGURE 21. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 22. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY PROCEDURE TYPE, 2027
FIGURE 23. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2027 (USD MILLION)
FIGURE 24. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FUNDOPLICATION PROCEDURES, 2018-2027 (USD MILLION)
FIGURE 25. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION, 2018-2027 (USD MILLION)
FIGURE 26. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY THERMAL ABLATION, 2018-2027 (USD MILLION)
FIGURE 27. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2021 VS 2027 (%)
FIGURE 28. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 29. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY DEVICE TYPE, 2027
FIGURE 30. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY BRAVO REFLUX TESTING SYSTEM, 2018-2027 (USD MILLION)
FIGURE 31. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIGITRAPPER REFLUX TESTING SYSTEM, 2018-2027 (USD MILLION)
FIGURE 32. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LINX MANAGEMENT SYSTEM, 2018-2027 (USD MILLION)
FIGURE 33. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MUSE -MEDIGUS ULTRASONIC SURGICAL ENDOSTAPLER, 2018-2027 (USD MILLION)
FIGURE 34. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY OTHERS, 2018-2027 (USD MILLION)
FIGURE 35. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STRETTA THERAPY, 2018-2027 (USD MILLION)
FIGURE 36. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2021 VS 2027 (%)
FIGURE 37. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 38. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY SURGERY TYPE, 2027
FIGURE 39. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2027 (USD MILLION)
FIGURE 40. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LINX REFLUX MANAGEMENT, 2018-2027 (USD MILLION)
FIGURE 41. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MEDIGUS ULTRASONIC SURGICAL ENDOSTAPLER, 2018-2027 (USD MILLION)
FIGURE 42. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2027 (USD MILLION)
FIGURE 43. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOCINCH ENDOLUMMINAL GASTROPLICATION, 2018-2027 (USD MILLION)
FIGURE 44. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC PLICATOR SYSTEM, 2018-2027 (USD MILLION)
FIGURE 45. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHYX, 2018-2027 (USD MILLION)
FIGURE 46. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PLEXIGLAS POLY-METHYL-METHACRYLATE (PMMA) MICROSPHERES, 2018-2027 (USD MILLION)
FIGURE 47. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STRETTA, 2018-2027 (USD MILLION)
FIGURE 48. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2021 VS 2027 (%)
FIGURE 49. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2021 VS 2027 (USD MILLION)
FIGURE 50. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY ROUTE OF ADMINISTRATION, 2027
FIGURE 51. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ORAL, 2018-2027 (USD MILLION)
FIGURE 52. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PARENTERAL, 2018-2027 (USD MILLION)
FIGURE 53. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2021 VS 2027 (%)
FIGURE 54. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2021 VS 2027 (USD MILLION)
FIGURE 55. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY DOSAGE FORM, 2027
FIGURE 56. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LIQUID, 2018-2027 (USD MILLION)
FIGURE 57. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SOLID, 2018-2027 (USD MILLION)
FIGURE 58. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2021 VS 2027 (%)
FIGURE 59. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2021 VS 2027 (USD MILLION)
FIGURE 60. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2027
FIGURE 61. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GOVERNMENT, 2018-2027 (USD MILLION)
FIGURE 62. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
FIGURE 63. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MEDICAL PRACTITIONERS, 2018-2027 (USD MILLION)
FIGURE 64. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY OTHERS, 2018-2027 (USD MILLION)
FIGURE 65. CALIFORNIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 66. FLORIDA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 67. ILLINOIS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 68. NEW YORK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 69. OHIO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 70. PENNSYLVANIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 71. TEXAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 72. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 73. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 74. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY STATE, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHAGOSCOPES AND GASTROSCOPES, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHAGOSCOPES AND GASTROSCOPES, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FUNDOPLICATION DEVICES, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FUNDOPLICATION DEVICES, BY STATE, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MANOMETRY SYSTEM, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MANOMETRY SYSTEM, BY STATE, 2018-2027 (USD MILLION)
TABLE 14. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PH MONITORING SYSTEM, 2018-2027 (USD MILLION)
TABLE 15. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PH MONITORING SYSTEM, BY STATE, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2027 (USD MILLION)
TABLE 17. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY STATE, 2018-2027 (USD MILLION)
TABLE 18. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPHINCTER AUGMENTATION DEVICES, 2018-2027 (USD MILLION)
TABLE 19. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPHINCTER AUGMENTATION DEVICES, BY STATE, 2018-2027 (USD MILLION)
TABLE 20. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, 2018-2027 (USD MILLION)
TABLE 21. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TREATMENT DEVICES, BY STATE, 2018-2027 (USD MILLION)
TABLE 22. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ULTRASONIC SURGICAL ENDOSTAPLER, 2018-2027 (USD MILLION)
TABLE 23. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ULTRASONIC SURGICAL ENDOSTAPLER, BY STATE, 2018-2027 (USD MILLION)
TABLE 24. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 25. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2027 (USD MILLION)
TABLE 26. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY STATE, 2018-2027 (USD MILLION)
TABLE 27. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FUNDOPLICATION PROCEDURES, 2018-2027 (USD MILLION)
TABLE 28. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY FUNDOPLICATION PROCEDURES, BY STATE, 2018-2027 (USD MILLION)
TABLE 29. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION, 2018-2027 (USD MILLION)
TABLE 30. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION, BY STATE, 2018-2027 (USD MILLION)
TABLE 31. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY THERMAL ABLATION, 2018-2027 (USD MILLION)
TABLE 32. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY THERMAL ABLATION, BY STATE, 2018-2027 (USD MILLION)
TABLE 33. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2027 (USD MILLION)
TABLE 34. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY BRAVO REFLUX TESTING SYSTEM, 2018-2027 (USD MILLION)
TABLE 35. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY BRAVO REFLUX TESTING SYSTEM, BY STATE, 2018-2027 (USD MILLION)
TABLE 36. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIGITRAPPER REFLUX TESTING SYSTEM, 2018-2027 (USD MILLION)
TABLE 37. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DIGITRAPPER REFLUX TESTING SYSTEM, BY STATE, 2018-2027 (USD MILLION)
TABLE 38. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LINX MANAGEMENT SYSTEM, 2018-2027 (USD MILLION)
TABLE 39. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LINX MANAGEMENT SYSTEM, BY STATE, 2018-2027 (USD MILLION)
TABLE 40. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MUSE -MEDIGUS ULTRASONIC SURGICAL ENDOSTAPLER, 2018-2027 (USD MILLION)
TABLE 41. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MUSE -MEDIGUS ULTRASONIC SURGICAL ENDOSTAPLER, BY STATE, 2018-2027 (USD MILLION)
TABLE 42. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY OTHERS, 2018-2027 (USD MILLION)
TABLE 43. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY OTHERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 44. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STRETTA THERAPY, 2018-2027 (USD MILLION)
TABLE 45. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STRETTA THERAPY, BY STATE, 2018-2027 (USD MILLION)
TABLE 46. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2027 (USD MILLION)
TABLE 47. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, 2018-2027 (USD MILLION)
TABLE 48. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY INVASIVE, BY STATE, 2018-2027 (USD MILLION)
TABLE 49. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LINX REFLUX MANAGEMENT, 2018-2027 (USD MILLION)
TABLE 50. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LINX REFLUX MANAGEMENT, BY STATE, 2018-2027 (USD MILLION)
TABLE 51. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MEDIGUS ULTRASONIC SURGICAL ENDOSTAPLER, 2018-2027 (USD MILLION)
TABLE 52. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MEDIGUS ULTRASONIC SURGICAL ENDOSTAPLER, BY STATE, 2018-2027 (USD MILLION)
TABLE 53. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, 2018-2027 (USD MILLION)
TABLE 54. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY NON-INVASIVE, BY STATE, 2018-2027 (USD MILLION)
TABLE 55. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOCINCH ENDOLUMMINAL GASTROPLICATION, 2018-2027 (USD MILLION)
TABLE 56. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOCINCH ENDOLUMMINAL GASTROPLICATION, BY STATE, 2018-2027 (USD MILLION)
TABLE 57. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC PLICATOR SYSTEM, 2018-2027 (USD MILLION)
TABLE 58. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC PLICATOR SYSTEM, BY STATE, 2018-2027 (USD MILLION)
TABLE 59. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHYX, 2018-2027 (USD MILLION)
TABLE 60. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ESOPHYX, BY STATE, 2018-2027 (USD MILLION)
TABLE 61. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PLEXIGLAS POLY-METHYL-METHACRYLATE (PMMA) MICROSPHERES, 2018-2027 (USD MILLION)
TABLE 62. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PLEXIGLAS POLY-METHYL-METHACRYLATE (PMMA) MICROSPHERES, BY STATE, 2018-2027 (USD MILLION)
TABLE 63. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STRETTA, 2018-2027 (USD MILLION)
TABLE 64. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY STRETTA, BY STATE, 2018-2027 (USD MILLION)
TABLE 65. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 66. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ORAL, 2018-2027 (USD MILLION)
TABLE 67. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ORAL, BY STATE, 2018-2027 (USD MILLION)
TABLE 68. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PARENTERAL, 2018-2027 (USD MILLION)
TABLE 69. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PARENTERAL, BY STATE, 2018-2027 (USD MILLION)
TABLE 70. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2027 (USD MILLION)
TABLE 71. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LIQUID, 2018-2027 (USD MILLION)
TABLE 72. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY LIQUID, BY STATE, 2018-2027 (USD MILLION)
TABLE 73. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SOLID, 2018-2027 (USD MILLION)
TABLE 74. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SOLID, BY STATE, 2018-2027 (USD MILLION)
TABLE 75. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 76. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GOVERNMENT, 2018-2027 (USD MILLION)
TABLE 77. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GOVERNMENT, BY STATE, 2018-2027 (USD MILLION)
TABLE 78. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
TABLE 79. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, BY STATE, 2018-2027 (USD MILLION)
TABLE 80. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MEDICAL PRACTITIONERS, 2018-2027 (USD MILLION)
TABLE 81. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MEDICAL PRACTITIONERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 82. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY OTHERS, 2018-2027 (USD MILLION)
TABLE 83. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY OTHERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 84. CALIFORNIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 85. CALIFORNIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 86. CALIFORNIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 87. CALIFORNIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2027 (USD MILLION)
TABLE 88. CALIFORNIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2027 (USD MILLION)
TABLE 89. CALIFORNIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 90. CALIFORNIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2027 (USD MILLION)
TABLE 91. CALIFORNIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 92. FLORIDA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 93. FLORIDA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 94. FLORIDA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 95. FLORIDA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2027 (USD MILLION)
TABLE 96. FLORIDA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2027 (USD MILLION)
TABLE 97. FLORIDA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 98. FLORIDA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2027 (USD MILLION)
TABLE 99. FLORIDA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 100. ILLINOIS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 101. ILLINOIS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 102. ILLINOIS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 103. ILLINOIS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2027 (USD MILLION)
TABLE 104. ILLINOIS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2027 (USD MILLION)
TABLE 105. ILLINOIS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 106. ILLINOIS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2027 (USD MILLION)
TABLE 107. ILLINOIS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 108. NEW YORK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 109. NEW YORK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 110. NEW YORK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 111. NEW YORK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2027 (USD MILLION)
TABLE 112. NEW YORK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2027 (USD MILLION)
TABLE 113. NEW YORK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 114. NEW YORK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2027 (USD MILLION)
TABLE 115. NEW YORK GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 116. OHIO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 117. OHIO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 118. OHIO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 119. OHIO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2027 (USD MILLION)
TABLE 120. OHIO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2027 (USD MILLION)
TABLE 121. OHIO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 122. OHIO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2027 (USD MILLION)
TABLE 123. OHIO GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 124. PENNSYLVANIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 125. PENNSYLVANIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 126. PENNSYLVANIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 127. PENNSYLVANIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2027 (USD MILLION)
TABLE 128. PENNSYLVANIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2027 (USD MILLION)
TABLE 129. PENNSYLVANIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 130. PENNSYLVANIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2027 (USD MILLION)
TABLE 131. PENNSYLVANIA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 132. TEXAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 133. TEXAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 134. TEXAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2027 (USD MILLION)
TABLE 135. TEXAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2027 (USD MILLION)
TABLE 136. TEXAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGERY TYPE, 2018-2027 (USD MILLION)
TABLE 137. TEXAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2027 (USD MILLION)
TABLE 138. TEXAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DOSAGE FORM, 2018-2027 (USD MILLION)
TABLE 139. TEXAS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 140. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 141. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 142. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 143. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET RANKING, BY KEY PLAYER, 2021
TABLE 144. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SHARE, BY KEY PLAYER, 2021
TABLE 145. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET MERGER & ACQUISITION
TABLE 146. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 147. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 148. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET INVESTMENT & FUNDING
TABLE 149. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 150. UNITED STATES GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET: LICENSE & PRICING

Companies Mentioned

  • Addex Pharmaceuticals Ltd.
  • Aros Pharma ApS
  • AstraZeneca Plc
  • C. R. Bard, Inc.,
  • Eisai Co., Ltd
  • EndoGastric Solutions, Inc.
  • KARL STORZ SE & Co. KG
  • MediGus Ltd.
  • Olympus Corporation
  • PENTAX Medical (Global)
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • The Procter & Gamble Company

Methodology

Loading
LOADING...